Assessment of Menopause Related Quality of Life Among Health Professionals in University Hospitals of UMC in Nur-Sultan

NCT ID: NCT04724135

Last Updated: 2021-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-30

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the quality of life of menopausal health-care providers in University Medical Center (UMC) hospitals in Nur-Sultan and identify whether there is a difference in the quality of life between two major groups of women health-care professionals: physicians and nurses, and to explore factors influencing on it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Quality of life has turned into a reference for the so-called "state of wellbeing" that includes six domains: physical health, social relationships, psychological state, spiritual concerns, environmental features, and level of independence. Quality of life is perceived as a major health component, especially for menopausal women, and has become an essential research topic that has been discussed widely in the literature.

Therefore, from the HRQoL perspective, the consequences of the climacterium should be considered as a specific aspect of health-related quality of life in studies that include this segment of the population. The increased life expectancy of the general population and of women in particular, has turned women's health care in this phase of life into a priority; the way this should be accomplished, however, represents one of the main sources of public health debate.

Quality of work life is a comprehensive and general schema, which is essential in improving specialized personnel's satisfaction and attracting and preserving personnel. It also results in positive theories such as increasing profits and provocation. Nevertheless, although physicians and nurses are expected to provide patient care and improve their quality of life, their own needs and their own quality of life have been either largely underestimated or ignored.

Providing care in these cases is very demanding in physical, emotional, and spiritual terms. Their work requires certain qualities, such as empathy, compassion, and closeness to the individuals and families they care for. Therefore, daily work may be significantly influenced by the menopausal transition, especially in nurses and physicians Work is beneficial for menopausal women by providing fulfilment, self-esteem, identity and social needs. But working environments like those with lack of temperature control, cramped conditions, some uniforms and stress can also make menopause symptoms worse. Menopause refers to the time when a woman's menstrual period stops for 12 consecutive months after the last period and is characterized by a decline in the production of the ovarian hormones, mainly estrogen and progesterone. The lack of these hormones makes some women prone to experiencing common symptoms that include, but are not limited to, sleep disorders, mood alterations, hot flashes, depression, urinary tract infections, vaginal infections, and increased risk for osteoporosis and cardiovascular diseases. Providing up-to-date information to women about menopause, its management, and the use of menopausal hormone therapy (MHT) may serve as an important step towards treating postmenopausal symptoms thereby improving the QOL of postmenopausal women.

According to a recent study, the level of awareness and knowledge of women about the menopause is directly proportional to their ability to control their symptoms as menopausal symptoms can have a negative impact on work but menopause in the workplace still remains a taboo. This study aims to investigate the QoL of menopausal health-care providers in UMC hospitals in Nur-Sultan and identify whether there is a difference in the quality of life between two major groups of women health-care professionals: physicians and nurses, and to explore factors influencing on it.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopause

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Female health-care givers aged 45 to 64 years. The study participants will be recruited from UMC (Clinical Academic Department (CAD) of Women's Health, Pediatric Clinical Academic Department, Republic Diagnostic Center (RDC) and National Center for Children's Rehabilitation (NCCR)), Nur-Sultan, Kazakhstan.

Survey

Intervention Type OTHER

The first part will assess the sociodemographic variables and reproductive characteristics, and the second part contain the Menopause-Specific Quality of Life (MENQOL) questionnaire The 29 questions of the MENQOL are divided into four domains: vasomotor (items 1-3), psychosocial (items 4-10), physical (items 11-26), and sexual (items 27-29).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey

The first part will assess the sociodemographic variables and reproductive characteristics, and the second part contain the Menopause-Specific Quality of Life (MENQOL) questionnaire The 29 questions of the MENQOL are divided into four domains: vasomotor (items 1-3), psychosocial (items 4-10), physical (items 11-26), and sexual (items 27-29).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* We will include all menopausal health-care providers working in CAD of Women's Health and Pediatric CAD UMC, NCCR, and RDC, Nur-Sultan Kazakhstan. In order to get the highest possible response rate as well as evaluate the non-response bias, there is a need to follow-up to those who did not responded.

Exclusion Criteria

* Women with serious health problems, such as severe chronic diseases, including psychological/psychiatric comorbidities, and use of specific drugs for them, will not be included in the study
Minimum Eligible Age

45 Years

Maximum Eligible Age

64 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of South Florida

OTHER

Sponsor Role collaborator

Università degli Studi dell'Insubria

OTHER

Sponsor Role collaborator

Nazarbayev University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gauri Bapayeva

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Milan Terzic, MD, PhD

Role: STUDY_DIRECTOR

Nazarbayev University Medical Center

Sanja Terzic, MD

Role: STUDY_DIRECTOR

Nazarbayev University Medical Center

Gauri Bapayeva, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Nazarbayev University Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gauri Bapayeva, MD, PhD

Role: CONTACT

+77017462800

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

024-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.